Page last updated: 2024-09-04

(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Gait Disorders, Animal

(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid has been researched along with Gait Disorders, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baizer, JS; Broussard, DM; Heskin-Sweezie, R; Titley, HK1

Other Studies

1 other study(ies) available for (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Gait Disorders, Animal

ArticleYear
Type B GABA receptors contribute to the restoration of balance during vestibular compensation in mice.
    Neuroscience, 2010, Aug-11, Volume: 169, Issue:1

    Topics: Adaptation, Physiological; Animals; Ataxia; Baclofen; Benzoates; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Lameness, Animal; Male; Mice; Mice, Inbred C57BL; Phenols; Phosphinic Acids; Postural Balance; Receptors, GABA-B; Recovery of Function; Reflex; Vestibular Nucleus, Lateral; Vestibule, Labyrinth

2010